Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Movement disorders in multiple sclerosis.
Mass lesions in the brain: tumor or multiple sclerosis? Clinical and imaging characteristics and course from a single reference center.
Long-term effects of fingolimod in multiple sclerosis: The randomized FREEDOMS extension trial.
Tremor in multiple sclerosis: The intriguing role of the cerebellum.
Curcumin Serves as a Human Kv1.3 Blocker to Inhibit Effector Memory T Lymphocyte Activities.
Estimating the Cost-Effectiveness of OnabotulinumtoxinA for Neurogenic Detrusor Overactivity in the United States.
Peli1 promotes microglia-mediated CNS inflammation by regulating Traf3 degradation.
Treatment of primary progressive multiple sclerosis.
Natalizumab saturation: biomarker for individual treatment holiday after natalizumab withdrawal?
Multiple sclerosis and herpesvirus interaction.
Relationships among physical inactivity, deconditioning, and walking impairment in persons with multiple sclerosis.
Neuromyelitis optica IgG does not alter aquaporin-4 water permeability, plasma membrane M1/M23 isoform content, or supramolecular assembly.
A Surprisingly Low Prevalence of Demonstrable Stress Urinary Incontinence and Pelvic Organ Prolapse in Women with Multiple Sclerosis Followed at a Tertiary Neurogenic Bladder Clinic.
Multiple sclerosis and palliative care - perceptions of severely affected multiple sclerosis patients and their health professionals: a qualitative study.
Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain.
γδ T cell subsets play opposing roles in regulating experimental autoimmune encephalomyelitis.
Sexual disorders in men with multiple sclerosis: Evaluation and management.
Acute Lymphoblastic Leukemia in a Man Treated With Fingolimod for Relapsing Multiple Sclerosis.
Purification of Mouse Brain Vessels.
Glia in mammalian development and disease.
Muscarinic receptor subtypes as potential targets to modulate oligodendrocyte progenitor survival, proliferation, and differentiation.
Prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: a blinded sonographic evaluation.
Coordinated control of oligodendrocyte development by extrinsic and intrinsic signaling cues.
The effects of bortezomib on the immune system: a focus on immune regulation.
Biological relevance of citrullinations: diagnostic, prognostic and therapeutic options.
Pages
« first
‹ previous
…
224
225
226
227
228
229
230
231
232
…
next ›
last »